Vaccination against Oncoproteins of HPV16 for Noninvasive Vulvar/Vaginal Lesions: Lesion Clearance Is Related to the Strength of the T-Cell Response by van Poelgeest, Mariëtte I E, Welters, Marij J P, Vermeij, Renee, Stynenbosch, Linda F M, Loof, Nikki M, Berends-van der Meer, Dorien M A, Löwik, Margriet J G, Hamming, Ineke L E, van Esch, Edith M G, Hellebrekers, Bart W J, van Beurden, Marc, Schreuder, Henk W, Kagie, Marjolein J, Trimbos, J Baptist M Z, Fathers, Lorraine M, Daemen, Toos, Hollema, Harry, Valentijn, A Rob P M, Oostendorp, Jaap, Oude Elberink, J Hanneke N G, Fleuren, Gertjan J, Bosse, Tjalling, Kenter, Gemma G, Stijnen, Theo, Nijman, Hans W, Melief, Cornelis J M, van der Burg, Sjoerd H

Get full text

Success or failure of vaccination for HPV16-positive vulvar lesions correlates with kinetics and phenotype of induced T-cell responses by Welters, Marij J. P., Kenter, Gemma G., de Vos van Steenwijk, Peggy J., Löwik, Margriet J. G., der Meer, Dorien M. A. Berends-van, Essahsah, Farah, Stynenbosch, Linda F. M., Vloon, Annelies P. G., Ramwadhdoebe, Tamara H., Piersma, Sytse J., van der Hulst, Jeanette M., Valentijn, A. Rob P. M., Fathers, Lorraine M., Drijfhout, Jan W., Franken, Kees L. M. C., Oostendorp, Jaap, Fleuren, Gert Jan, Melief, Cornelis J. M., van der Burg, Sjoerd H., van Rood, Johannes J.

Get full text

The long-term immune response after HPV16 peptide vaccination in women with low-grade pre-malignant disorders of the uterine cervix: a placebo-controlled phase II study by de Vos van Steenwijk, Peggy J., van Poelgeest, Mariette I. E., Ramwadhdoebe, Tamara H., Löwik, Margriet J. G., Berends-van der Meer, Dorien M. A., van der Minne, Caroline E., Loof, Nikki M., Stynenbosch, Linda F. M., Fathers, Lorraine M., Valentijn, A. Rob P. M., Oostendorp, Jaap, Osse, Elisabeth M., Fleuren, Gert Jan, Nooij, Linda, Kagie, Marjolein J., Hellebrekers, Bart W. J., Melief, Cornelis J. M., Welters, Marij J. P., van der Burg, Sjoerd H., Kenter, Gemma G.

Get full text

The simultaneous ex vivo detection of low-frequency antigen-specific CD4+ and CD8+ T-cell responses using overlapping peptide pools by Singh, Satwinder Kaur, Meyering, Maaike, Ramwadhdoebe, Tamara H., Stynenbosch, Linda F. M., Redeker, Anke, Kuppen, Peter J. K., Melief, Cornelis J. M., Welters, Marij J. P., van der Burg, Sjoerd H.

Get full text

Harmonisation of short-term in vitro culture for the expansion of antigen-specific CD8 super(+) T cells with detection by ELISPOT and HLA-multimer staining by Chudley, Lindsey, McCann, Katy J, Coleman, Adam, Cazaly, Angelica M, Bidmon, Nicole, Britten, Cedrik M, Burg, Sjoerd H, Gouttefangeas, Cecile, Jandus, Camilla, Laske, Karoline, Maurer, Dominik, Romero, Pedro, Schroder, Helene, Stynenbosch, Linda FM, Walter, Steffen, Welters, Marij JP, Ottensmeier, Christian H

Get full text

Addition of interferon-[alpha] to the p53-SLP vaccine results in increased production of interferon-[gamma] in vaccinated colorectal cancer patients: A phase I/II clinical trial by Zeestraten, Eliane CM, Speetjens, Frank M, Welters, Marij JP, Saadatmand, Sepideh, Stynenbosch, Linda FM, Jongen, Rogier, Kapiteijn, Ellen, Gelderblom, Hans, Nijman, Hans W, Valentijn, A Rob PM, Oostendorp, Jaap, Fathers, Lorraine M, Drijfhout, Jan W, van de Velde, Cornelis JH, Kuppen, Peter JK, van der Burg, Sjoerd H, Melief, Cornelis JM

Get full text

Addition of interferon-[alpha] to the p53-SLP registered vaccine results in increased production of interferon-[gamma] in vaccinated colorectal cancer patients: A phase I/II clinic... by Zeestraten, Eliane CM, Speetjens, Frank M, Welters, Marij JP, Saadatmand, Sepideh, Stynenbosch, Linda FM, Jongen, Rogier, Kapiteijn, Ellen, Gelderblom, Hans, Nijman, Hans W, Valentijn, ARob PM, Oostendorp, Jaap, Fathers, Lorraine M, Drijfhout, Jan W, van de Velde, Cornelis JH, Kuppen, Peter JK, van der Burg, Sjoerd H, Melief, Cornelis JM

Get full text